Jesse Stoff
Allergy & Immunology · Glen Cove, NYNPI 1477637312
Payments from drug & device makers
Across 453 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Nestle Healthcare Nutrition Inc.$1K
- E.r. Squibb & Sons, L.L.C.$654
- Pfizer$598
- QOL Medical, LLC$587
- Aimmune Therapeutics, Inc.$510
- plus $3K from 29 others
What the payments were for
- Food & beverage$9,074100%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 180 | $2,720 |
| Nestle Healthcare Nutrition Inc. | 50 | $1,146 |
| E.r. Squibb & Sons, L.L.C. | 28 | $654 |
| Pfizer | 30 | $598 |
| QOL Medical, LLC | 22 | $587 |
| Aimmune Therapeutics, Inc. | 17 | $510 |
| GSK | 12 | $415 |
| Regeneron Healthcare Solutions, Inc. | 8 | $378 |
| Grifols USA, LLC | 10 | $239 |
| Vivus LLC | 11 | $223 |
| CSL Behring | 10 | $186 |
| Menarini Silicon Biosystems, Inc. | 8 | $162 |
| Lundbeck LLC | 8 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $131 |
| Mirati Therapeutics, Inc. | 6 | $130 |
| Foundation Medicine, Inc. | 6 | $102 |
| Acella Pharmaceuticals, LLC | 5 | $101 |
| Stemline Therapeutics Inc. | 3 | $78 |
| Pharmacosmos Therapeutics Inc. | 3 | $56 |
| Azurity Pharmaceuticals, Inc. | 3 | $54 |
| Exact Sciences | 2 | $51 |
| Merck | 3 | $51 |
| Tempus AI, Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| Genentech USA, Inc. | 3 | $43 |
| Pharmaand GmbH | 2 | $42 |
| Eisai Inc. | 2 | $39 |
| EMD Serono, Inc. | 2 | $38 |
| Blueprint Medicines Corporation | 2 | $28 |
| Tolmar, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $19 |
| Clarus Therapeutics Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,116 in reported general payments places this provider in the 70th percentile of 320 allergy & immunology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PiqrayAlpelisib | 13 | $332,772 |
| ZenpepLipase/Protease/Amylase | 43 | $234,586 |
| BuphenylSodium Phenylbutyrate | 11 | $221,293 |
| LynparzaOlaparib | 13 | $217,169 |
| CreonLipase/Protease/Amylase | 71 | $196,360 |
| BrukinsaZanubrutinib | 11 | $167,052 |
| XtandiEnzalutamide | 19 | $161,057 |
| Taltz AutoinjectorIxekizumab | 12 | $81,329 |
| JanumetSitagliptin Phos/Metformin Hcl | 26 | $14,438 |
| EliquisApixaban | 16 | $12,176 |
| VascepaIcosapent Ethyl | 25 | $8,924 |
| Armour ThyroidThyroid,pork | 108 | $5,755 |
| Sucralfate | 29 | $4,184 |
| DayvigoLemborexant | 12 | $3,824 |
| CombiganBrimonidine Tartrate/Timolol | 16 | $3,215 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Aimmune Therapeutics, Inc.Zenpep | $510 | $234,58643 claims |
| AbbVieCreon, Armour Thyroid, Combigan | $2,720 | $205,330195 claims |
| MerckJanumet | $51 | $14,43826 claims |
| PfizerEliquis | $598 | $12,17616 claims |
| Eisai Inc.Dayvigo | $39 | $3,82412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in Glen Cove
- Peter DeaneRochester$3.7M
- Syed MustafaRochester$3.6M
- Golda HudesBronx$2.4M
- Arye RubinsteinBronx$1.1M
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$980K
- Mili ShumWest Harrison$924K
- Paula BusseNew York$821K
- Gregory PuglisiPlainview$813K
- Stanley GoldsteinRockville Centre$653K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.